There are errors in the Funding statement. The correct Funding statement is as follows: This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C1851) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007648 and 2020R1I1A1A01072520).
Reference
- 1. Moon SJ, Jhun J, Ryu J, Kwon Jy, Kim SY, et al. (2021) The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines. PLOS ONE 16(2): e0245986. https://doi.org/10.1371/journal.pone.0245986 pmid:33592002
Citation: Moon S-J, Jhun J, Ryu J, Kwon Jy, Kim S-Y, Jung K, et al. (2021) Correction: The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines. PLoS ONE 16(8): e0256716. https://doi.org/10.1371/journal.pone.0256716
Published: August 19, 2021
Copyright: © 2021 Moon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.